Suchergebnisse - "Shelton, Edward"

PubPharm (29)

1

Letter : Transperineal ultrasonography for ulcerative proctitis- Applicability in the pregnant population?

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Greeve, T. | Prentice, R. | Shelton, E. | +3

CommentOn: Aliment Pharmacol Ther. 2022 May;55(10):1320-1329. - PMID 35218038

2

Impact of a pharmacist-led thiopurine monitoring service in outpatients with inflammatory bowel disease

enthalten in: Internal medicine journal | 2023

von Rodda, S. | Fildes, K. | Shelton, E. | +2

3

Impact of a pharmacist‐led thiopurine monitoring service in outpatients with inflammatory bowel disease

enthalten in: Internal Medicine Journal | 2023

von Rodda, S. | Fildes, K. | Shelton, E. | +2

4

Getting to the bottom of persistent proctitis

enthalten in: Internal medicine journal | 2022

von Hirsch, R. | Tambakis, G. | Shelton, E.

5

Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT) : an open-label, single-centre, randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Schulberg, J. | Wright, E. | Holt, B. | +15

6

Getting to the bottom of persistent proctitis

enthalten in: Internal Medicine Journal | 2022

von Hirsch, R. | Tambakis, G. | Shelton, E.

7

A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive

enthalten in: Inflammatory bowel diseases | 2021

von Flanagan, E. | Wright, E. | Sparrow, M. | +14

8

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2021

von Maconi, G. | Bosetti, C. | De Monti, A. | +21

CommentIn: Scand J Gastroenterol. 2021 Jun;56(6):656-660. - PMID 33765405

9

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +19

10

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary Pharmacology & Therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +18